Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (15)
Leukemia (5)
Blood Cancer Journal (2)
Nature Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (16)
Correspondence (5)
Amendments and Corrections (2)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Genetics
Health care
Medical research
Oncology
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–23 of 23 results

Advanced filters: Author: Georg-Nikolaus Franke Clear advanced filters

Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

Katia Perruccio
Katherine N. Ward
Simone Cesaro
Research03 Jun 2025
Bone Marrow Transplantation

Volume: 60, P: 1243-1248
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)

Christian Niederwieser
Simona Iacobelli
Nicolaus Kröger
ResearchOpen Access25 Apr 2024
Bone Marrow Transplantation

Volume: 59, P: 1084-1091
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma

Merz and colleagues perform single-cell multiomic analysis of mononuclear cells isolated from individuals receiving BCMA-directed CAR T cell therapy for myeloma and show that nonresponders are characterized by an immune-suppressive microenvironment.

Michael Rade
Nora Grieb
Maximilian Merz
Research19 Apr 2024
Nature Cancer

Volume: 5, P: 1318-1333
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation

Juliane Grimm
Marius Bill
Sebastian Schwind
Research30 Nov 2018
Bone Marrow Transplantation

Volume: 54, P: 1189-1197
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation

Philipp Ernst
Jenny Rinke
Andreas Hochhaus
ResearchOpen Access04 Jul 2024
Leukemia

Volume: 38, P: 2037-2040
Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Jule Ussmann
Lara Bischof
Madlen Jentzsch
CorrespondenceOpen Access12 Jun 2025
Blood Cancer Journal

Volume: 15, P: 1-6
Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation

Lara Bischof
Jule Ussmann
Madlen Jentzsch
ResearchOpen Access25 Oct 2023
Leukemia

Volume: 38, P: 198-201
Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

Thomas Karlas
Tina Weiße
Georg-Nikolaus Franke
Amendments and Corrections19 Mar 2019
Bone Marrow Transplantation

Volume: 54, P: 1920
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Nora Grieb
Alexander Oeser
Maximilian Merz
ResearchOpen Access05 Dec 2024
Bone Marrow Transplantation

Volume: 60, P: 335-345
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis

Osama Ahmad
Nicolaus Kröger
Maximilian Christopeit
CorrespondenceOpen Access12 Mar 2025
Bone Marrow Transplantation

Volume: 60, P: 733-736
How risky is a second allogeneic stem cell transplantation?

Olaf Penack
Mouad Abouqateb
Zinaida Peric
ResearchOpen Access25 Jun 2024
Leukemia

Volume: 38, P: 1799-1807
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry

Annamaria Brioli
Elza Lomaia
Michael Lauseker
ResearchOpen Access28 Mar 2024
Leukemia

Volume: 38, P: 1072-1080
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

Luise Fischer
Nora Grieb
Maximilian Merz
ResearchOpen Access06 Jan 2024
Leukemia

Volume: 38, P: 372-382
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT

Arnon Nagler
Myriam Labopin
Mohamad Mohty
Research02 Sept 2023
Bone Marrow Transplantation

Volume: 58, P: 1339-1347
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Madlen Jentzsch
Lara Bischof
Sebastian Schwind
ResearchOpen Access19 Dec 2022
Blood Cancer Journal

Volume: 12, P: 1-10
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

Arnon Nagler
Christophe Peczynski
Mohamad Mohty
Research30 Apr 2022
Bone Marrow Transplantation

Volume: 57, P: 1116-1123
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

Donata Backhaus
Dominic Brauer
Sebastian Schwind
ResearchOpen Access04 Oct 2022
Bone Marrow Transplantation

Volume: 58, P: 30-38
Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

Thomas Karlas
Tina Weiße
Georg-Nikolaus Franke
Research26 Feb 2019
Bone Marrow Transplantation

Volume: 54, P: 1738-1746
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study

Arnon Nagler
Bhagirathbhai Dholaria
Mohamad Mohty
Research19 Jun 2020
Bone Marrow Transplantation

Volume: 56, P: 20-29
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

Arnon Nagler
Christophe Peczynski
Mohamad Mohty
Amendments and Corrections07 Oct 2022
Bone Marrow Transplantation

Volume: 57, P: 1854
Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

Saskia Hell
Madlen Jentzsch
Vladan Vucinic
CorrespondenceOpen Access18 Feb 2022
Bone Marrow Transplantation

Volume: 57, P: 824-826
Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation

Madlen Jentzsch
Juliane Grimm
Sebastian Schwind
CorrespondenceOpen Access15 Jul 2021
Bone Marrow Transplantation

Volume: 56, P: 2610-2612
Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation

Laura K. Schmalbrock
Lynn Bonifacio
Sebastian Schwind
Correspondence15 Jan 2018
Bone Marrow Transplantation

Volume: 53, P: 640-643

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)

Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma

Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation

Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation

Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation

Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis

How risky is a second allogeneic stem cell transplantation?

Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation

Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation

Search

Quick links